Baart, Victor M.
van Manen, Labrinus
Bhairosingh, Shadhvi S.
Vuijk, Floris A.
Iamele, Luisa
de Jonge, Hugo
Scotti, Claudia
Resnati, Massimo
Cordfunke, Robert A.
Kuppen, Peter J. K.
Mazar, Andrew P.
Burggraaf, Jacobus
Vahrmeijer, Alexander L.
Sier, Cornelis F. M.
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (872860 - PRISAR2, 857894 - CAST)
Article History
Received: 2 June 2021
Revised: 27 August 2021
Accepted: 21 September 2021
First Online: 12 October 2021
Declarations
:
: This article does not contain any studies with human participants.All animal experiments were approved by the Dutch Central Commission for Animal Experimentation (AVD1160020172925). Experiments were performed in accordance with the code of practice “Dierproeven In Het Kankeronderzoek.” All applicable institutional and/or national guidelines for the care and use of animals were followed.
: Dr. Iamele, Dr. de Jonge, and Dr Scotti report non-financial support from Ardis S.r.l., during the conduct of the study. Dr. Mazar reports personal fees and other from Monopar Therapeutics, outside the submitted work. In addition, Dr. Mazar has a patent US 8105602; US 8101726 issued. All other authors have nothing to disclose.